These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 19504000
1. Chemoprevention by celecoxib in reflux-induced gastric adenocarcinoma in Wistar rats that underwent gastrojejunostomy. Rocha FT, Lourenço LG, Jucá MJ, Costa V, Leal AT. Acta Cir Bras; 2009; 24(3):189-94. PubMed ID: 19504000 [Abstract] [Full Text] [Related]
2. Late administration of a specific COX-2 inhibitor does not treat and/or prevent progression of gastric tumors in rats submitted to duodenogastric reflux procedure. Rodrigues PA, Naresse LE, Rodrigues MA, Kobayasi S. Acta Cir Bras; 2013 Jun; 28(6):453-7. PubMed ID: 23743684 [Abstract] [Full Text] [Related]
3. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats]. Tang BD, Zeng ZR, Hu PJ. Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761 [Abstract] [Full Text] [Related]
4. [An experimental study on chemoprevention of esophageal adenocarcinoma by celecoxib, a selective cyclooxygenase-2 inhibitor]. Zhang T, Su LW, Zhu YF, Lang HJ, Zhang F, Zhou YA, Liang XH, Wang YJ. Zhonghua Wei Chang Wai Ke Za Zhi; 2012 May; 15(5):512-6. PubMed ID: 22648851 [Abstract] [Full Text] [Related]
7. Chemoprevention of gastric cancer by celecoxib in rats. Hu PJ, Yu J, Zeng ZR, Leung WK, Lin HL, Tang BD, Bai AH, Sung JJ. Gut; 2004 Feb; 53(2):195-200. PubMed ID: 14724149 [Abstract] [Full Text] [Related]
8. Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: implications on chemoprevention. Yu J, Tang BD, Leung WK, To KF, Bai AH, Zeng ZR, Ma PK, Go MY, Hu PJ, Sung JJ. World J Gastroenterol; 2005 Jan 07; 11(1):41-5. PubMed ID: 15609394 [Abstract] [Full Text] [Related]
9. Pathogenesis of adenocarcinoma induced by gastrojejunostomy in Wistar rats: role of duodenogastric reflux. Kondo K, Kojima H, Akiyama S, Ito K, Takagi H. Carcinogenesis; 1995 Aug 07; 16(8):1747-51. PubMed ID: 7634399 [Abstract] [Full Text] [Related]
10. Does troncular vagotomy modify the proliferative gastric lesions induced in rats by duodenogastric reflux? Rodrigues PA, Kobayasi S, Rodrigues MA. Acta Cir Bras; 2007 Aug 07; 22(3):210-4. PubMed ID: 17546294 [Abstract] [Full Text] [Related]
11. Short-term celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model. Kuo CH, Hu HM, Tsai PY, Wu IC, Yang SF, Chang LL, Wang JY, Jan CM, Wang WM, Wu DC. World J Gastroenterol; 2009 Oct 21; 15(39):4907-14. PubMed ID: 19842220 [Abstract] [Full Text] [Related]
12. Chemoprevention of glandular stomach carcinogenesis through duodenogastric reflux in rats by a COX-2 inhibitor. Oba M, Miwa K, Fujimura T, Harada S, Sasaki S, Hattori T. Int J Cancer; 2008 Oct 01; 123(7):1491-8. PubMed ID: 18646190 [Abstract] [Full Text] [Related]
13. [The influence of reflux of bile and pancreatic juice on gastric carcinogenesis in rats]. Kojima H, Kondo K, Takagi H. Nihon Geka Gakkai Zasshi; 1990 Jul 01; 91(7):818-26. PubMed ID: 2398876 [Abstract] [Full Text] [Related]
14. [Duodenogastric reflux and gastric carcinogenesis in rats]. Hasegawa H. Nihon Shokakibyo Gakkai Zasshi; 1991 Aug 01; 88(8):1517-24. PubMed ID: 1942605 [Abstract] [Full Text] [Related]
15. [Cyclooxygenase (COX)-2 expression in a rat duodenoesophageal reflux model and chemoprevention of adenocarcinoma by the selective COX-2 inhibitor nimesulide]. Oyama K, Fujimura T, Ninomiya I, Miyashita T, Kinami S, Fushida S, Ohta T. Nihon Shokakibyo Gakkai Zasshi; 2007 Aug 01; 104(8):1183-91. PubMed ID: 17675820 [Abstract] [Full Text] [Related]
16. Omeprazole and adenocarcinoma in the stomach of rats submitted to duodenogastric reflux. Is there a protective effect? Monteiro RLR, Kobayasi MAMR, Araujo MR, Monteiro DR, Andreollo NA. Acta Cir Bras; 2020 Aug 01; 35(9):e202000904. PubMed ID: 33027361 [Abstract] [Full Text] [Related]
17. The role of duodenogastric reflux in formation of precarcinogenic gastric lesions--an experimental study. Zlatić A, Stojanović M, Mihailović D, Dinić BR, Protić M, Veljković R. Med Pregl; 2013 Aug 01; 66(7-8):285-91. PubMed ID: 24069809 [Abstract] [Full Text] [Related]
18. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Wong BC, Zhang L, Ma JL, Pan KF, Li JY, Shen L, Liu WD, Feng GS, Zhang XD, Li J, Lu AP, Xia HH, Lam S, You WC. Gut; 2012 Jun 01; 61(6):812-8. PubMed ID: 21917649 [Abstract] [Full Text] [Related]
19. Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: morphology, mucin histochemistry, polyamine metabolism, and labelling index. Taylor PR, Mason RC, Filipe MI, Vaja S, Hanley DC, Murphy GM, Dowling RH, McColl I. Gut; 1991 Dec 01; 32(12):1447-54. PubMed ID: 1773947 [Abstract] [Full Text] [Related]
20. Inhibition of cyclooxygenase-2 causes regression of gastric adenomas in trefoil factor 1 deficient mice. Thiel A, Narko K, Heinonen M, Hemmes A, Tomasetto C, Rio MC, Haglund C, Mäkelä TP, Ristimäki A. Int J Cancer; 2012 Sep 01; 131(5):1032-41. PubMed ID: 22034055 [Abstract] [Full Text] [Related] Page: [Next] [New Search]